2018 annual financial data
Cartesian Therapeutics 2018 Operating margin
Direct answer
Operating margin was -7,200.66%.
Operating income was -65,022,000 USD and net income was -65,336,000 USD.
Operating cash flow was -59,161,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 903,000 USD
- Operating income
- -65,022,000 USD
- Net income
- -65,336,000 USD
- Operating cash flow
- -59,161,000 USD